Primary and malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, but are insensitive to direct activation with exogenous Fas ligand
- PMID: 21103345
- PMCID: PMC2984448
- DOI: 10.1371/journal.pone.0014037
Primary and malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, but are insensitive to direct activation with exogenous Fas ligand
Abstract
Introduction: Cholangiocarcinoma is a rare malignancy of the biliary tract, the incidence of which is rising, but the pathogenesis of which remains uncertain. No common genetic defects have been described but it is accepted that chronic inflammation is an important contributing factor. We have shown that primary human cholangiocyte and hepatocyte survival is tightly regulated via co-operative interactions between two tumour necrosis family (TNF) receptor family members; CD40 and Fas (CD95). Functional deficiency of CD154, the ligand for CD40, leads to a failure of clearance of biliary tract infections and a predisposition to cholangiocarcinoma implying a direct link between TNF receptor-mediated apoptosis and the development of cholangiocarcinoma.
Aims: To determine whether malignant cholangiocytes display defects in CD40 mediated apoptosis. By comparing CD40 and Fas-mediated apoptosis and intracellular signalling in primary human cholangiocytes and three cholangiocyte cell lines.
Results: Primary cholangiocytes and cholangiocyte cell lines were relatively insensitive to direct Fas-mediated killing with exogenous FasL when compared with Jurkat cells, which readily underwent Fas-mediated apoptosis, but were extremely sensitive to CD154 stimulation. The sensitivity of cells to CD40 activation was similar in magnitude in both primary and malignant cells and was STAT-3 and AP-1 dependent in both.
Conclusions: 1) Both primary and malignant cholangiocytes are relatively resistant to Fas-mediated killing but show exquisite sensitivity to CD154, suggesting that the CD40 pathway is intact and fully functional in both primary and malignant cholangiocytes 2) The relative insensitivity of cholangiocytes to Fas activation demonstrates the importance of CD40 augmentation of Fas dependent death in these cells. Agonistic therapies which target CD40 and associated intracellular signalling pathways may be effective in promoting apoptosis of malignant cholangiocytes.
Conflict of interest statement
Figures




Similar articles
-
CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.FASEB J. 2001 Nov;15(13):2345-54. doi: 10.1096/fj.01-0088com. FASEB J. 2001. PMID: 11689460
-
CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2.Cell Signal. 2006 Apr;18(4):456-68. doi: 10.1016/j.cellsig.2005.05.015. Epub 2005 Jun 20. Cell Signal. 2006. PMID: 15970430
-
Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion.Hepatology. 2008 Feb;47(2):552-62. doi: 10.1002/hep.22011. Hepatology. 2008. PMID: 17999420
-
Programmed cell death: the influence of CD40, CD95 (Fas or Apo-I) and their ligands.Med Oncol. 1998 Apr;15(1):15-9. doi: 10.1007/BF02787339. Med Oncol. 1998. PMID: 9643525 Review.
-
Effector mechanisms of nonsuppurative destructive cholangitis in graft-versus-host disease and allograft rejection.Semin Liver Dis. 2005 Aug;25(3):281-97. doi: 10.1055/s-2005-916320. Semin Liver Dis. 2005. PMID: 16143944 Review.
Cited by
-
Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells.Hepatology. 2014 Aug;60(2):700-14. doi: 10.1002/hep.27165. Epub 2014 Jun 20. Hepatology. 2014. PMID: 24715669 Free PMC article.
-
Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer.Br J Cancer. 2013 Nov 12;109(10):2665-74. doi: 10.1038/bjc.2013.610. Epub 2013 Oct 17. Br J Cancer. 2013. PMID: 24136146 Free PMC article.
-
Saturated free fatty acids induce cholangiocyte lipoapoptosis.Hepatology. 2014 Dec;60(6):1942-56. doi: 10.1002/hep.27175. Epub 2014 Jun 20. Hepatology. 2014. PMID: 24753158 Free PMC article.
-
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review).Int J Oncol. 2023 Dec;63(6):137. doi: 10.3892/ijo.2023.5585. Epub 2023 Oct 27. Int J Oncol. 2023. PMID: 37888583 Free PMC article. Review.
-
Clearance of Apoptotic Cells by Tissue Epithelia: A Putative Role for Hepatocytes in Liver Efferocytosis.Front Immunol. 2018 Jan 25;9:44. doi: 10.3389/fimmu.2018.00044. eCollection 2018. Front Immunol. 2018. PMID: 29422896 Free PMC article. Review.
References
-
- Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991;66:233–243. - PubMed
-
- Suda T, Takahashi P, Goldstein P, Nagata S. Molecular cloning and expression of Fas ligand, a novel member of the tumour necrosis family. Cell. 1993;75:1169–1178. - PubMed
-
- French LE, Hahne M, Viarde I, Radlgrubber G, Zanone R, et al. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and co expression in adult tissues characterized by apoptotic cell turnover. Journal of Cell Biology. 1996;133(2):335–343. - PMC - PubMed
-
- Bonfoco E, Stuart PM, Brunner T, Lin T, Griffith TS, et al. Inducible non-lymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity. 1998;9:711–720. - PubMed
-
- Harada K, Ozaki S, Gershwin ME, Nakanuma Y. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology. 1997;26(6):1399–1405. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous